Shandong Jincheng Pharmaceutical Group Co., Ltd operates primarily in the pharmaceutical industry, specializing in the research, development, manufacturing, and distribution of a broad range of pharmaceutical products. Its core product portfolio includes active pharmaceutical ingredients (APIs), bulk drugs, chemical pharmaceuticals, traditional Chinese medicines, and healthcare products. The company manufactures pharmaceutical intermediates, APIs for cardiovascular, anti-inflammatory, and antimicrobial agents; traditional Chinese medicine extracts; formulated medicines such as tablets, capsules, and injections; as well as nutritional supplements and health-related products.
Founded in 2001 and headquartered in Jinan, Shandong Province, China, the company serves domestic and international markets through its extensive sales network and subsidiary operations. It is engaged in various business segments including pharmaceutical technology, chemical synthesis, and pharmaceutical healthcare product services, targeting hospitals, pharmacies, and healthcare institutions primarily in China while expanding its footprint globally.
In recent years, Shandong Jincheng Pharmaceutical Group has implemented significant strategic initiatives including forming partnerships to enhance its pharmaceutical research and development capabilities, launching new product lines in advanced drug formulations, and expanding its manufacturing capacity to meet rising demand. The company has also pursued acquisitions to broaden its product portfolio and has focused on innovation in traditional Chinese medicine integrated with modern pharmaceutical technologies, reflecting a strategic shift toward higher value-added pharmaceutical products and greater market diversification.
Overall, Shandong Jincheng Pharmaceutical Group Co., Ltd is a comprehensive pharmaceutical enterprise that combines traditional and modern pharmaceutical products, scientific research services, and healthcare solutions with an emphasis on innovation and market expansion.